Fragoulis GE[au] - Search Results

Year	Number of Results
2008	2
2010	1
2012	1
2014	3
2015	3
2016	4
2017	4
2018	6
2019	17
2020	24
2021	20
2022	26
2023	3

1

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis.

Fragoulis GE, McInnes IB, Siebert S. Fragoulis GE, et al. Rheumatology (Oxford). 2019 Feb 1;58(Suppl 1):i43-i54. doi: 10.1093/rheumatology/key276. Rheumatology (Oxford). 2019. PMID: 30806709 Free PMC article. Review.

2

Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment.

Fragoulis GE, Liava C, Daoussis D, Akriviadis E, Garyfallos A, Dimitroulas T. Fragoulis GE, et al. World J Gastroenterol. 2019 May 14;25(18):2162-2176. doi: 10.3748/wjg.v25.i18.2162. World J Gastroenterol. 2019. PMID: 31143068 Free PMC article. Review.

3

Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment.

Fragoulis GE, Nikiphorou E, Larsen J, Korsten P, Conway R. Fragoulis GE, et al. Front Med (Lausanne). 2019 Oct 23;6:238. doi: 10.3389/fmed.2019.00238. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31709258 Free PMC article. Review.

4

Treatment strategies in axial spondyloarthritis: what, when and how?

Fragoulis GE, Siebert S. Fragoulis GE, et al. Rheumatology (Oxford). 2020 Oct 1;59(Suppl4):iv79-iv89. doi: 10.1093/rheumatology/keaa435. Rheumatology (Oxford). 2020. PMID: 33053192 Free PMC article. Review.

5

2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis.

Nikiphorou E, Santos EJF, Marques A, Böhm P, Bijlsma JW, Daien CI, Esbensen BA, Ferreira RJO, Fragoulis GE, Holmes P, McBain H, Metsios GS, Moe RH, Stamm TA, de Thurah A, Zabalan C, Carmona L, Bosworth A. Nikiphorou E, et al. Among authors: fragoulis ge. Ann Rheum Dis. 2021 Oct;80(10):1278-1285. doi: 10.1136/annrheumdis-2021-220249. Epub 2021 May 7. Ann Rheum Dis. 2021. PMID: 33962964 Free PMC article.

6

MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact.

Evangelatos G, Fragoulis GE, Koulouri V, Lambrou GI. Evangelatos G, et al. Among authors: fragoulis ge. Autoimmun Rev. 2019 Nov;18(11):102391. doi: 10.1016/j.autrev.2019.102391. Epub 2019 Sep 11. Autoimmun Rev. 2019. PMID: 31520804 Review.

7

Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature.

Fragoulis GE, Conway R, Nikiphorou E. Fragoulis GE, et al. Rheumatology (Oxford). 2019 Nov 1;58(11):1900-1906. doi: 10.1093/rheumatology/kez337. Rheumatology (Oxford). 2019. PMID: 31504978 Review.

8

Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors.

Evangelatos G, Koulouri V, Iliopoulos A, Fragoulis GE. Evangelatos G, et al. Among authors: fragoulis ge. Ther Adv Musculoskelet Dis. 2020 Jun 22;12:1759720X20930116. doi: 10.1177/1759720X20930116. eCollection 2020. Ther Adv Musculoskelet Dis. 2020. PMID: 32612710 Free PMC article. Review.

9

Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.

Fragoulis GE, Dey M, Zhao S, Schoones J, Courvoisier D, Galloway J, Hyrich KL, Nikiphorou E. Fragoulis GE, et al. RMD Open. 2022 Nov;8(2):e002726. doi: 10.1136/rmdopen-2022-002726. RMD Open. 2022. PMID: 36323488 Free PMC article. Review.

10

Cardiovascular disease in psoriatic arthritis: facts and unmet needs.

Gialouri CG, Fragoulis GE. Gialouri CG, et al. Among authors: fragoulis ge. Rheumatology (Oxford). 2022 Apr 11;61(4):1305-1306. doi: 10.1093/rheumatology/keab655. Rheumatology (Oxford). 2022. PMID: 34508550 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results